NASDAQ · Medical - Equipment & Services

CapsoVision, Inc. (CV) Stock

$6.64 +0.30% NASDAQ: CV Healthcare

Valuation

MetricValue
Price$6.64
Market Cap$331.76M
P/E Ratio-9.79
P/B Ratio23.40
P/S Ratio22.19
EPS (TTM)$0.00
52-Week High$15.37
52-Week Low$4.38
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-177.85%
ROA-160.64%
ROCE-164.32%
Gross Margin7.14%
Operating Margin-185.71%
Net Margin-214.74%
Debt/Equity0.05
Current Ratio4.25

Annual Financials (USD)

Metric202320242025
Revenue$10.0M$12.0M$14.0M
Operating Profit$-11.0M$-20.0M$-26.0M
Net Profit$-11.0M$-20.0M$-25.0M
EPS$-0.29$-0.43$-0.54
Op Margin-116.3%-169.4%-188.3%

Balance Sheet (USD)

Metric202320242025
Total Assets$22.0M$17.0M$18.0M
Total Liabilities$131.0M$146.0M$5.0M
Cash$15.0M$9.0M$10.0M
Borrowings$2.0M$1.0M$1.0M

Latest News

CapsoVision Appoints Gastroenterology Leader David S. Shields, M.D., to Board of Directors GlobeNewswire · Jul 2, 2026 CapsoVision Q1 Earnings Call Highlights MarketBeat · May 14, 2026 CapsoVision Reports First Quarter 2026 Financial Results GlobeNewswire · May 14, 2026 CapsoVision to Release First Quarter 2026 Financial Results on May 14, 2026 GlobeNewswire · Apr 30, 2026 CapsoVision And 2 Other Growth Stocks With Significant Insider Ownership Simply Wall St. · Apr 24, 2026

Cash Flow (USD)

Metric202320242025
Operating Cash Flow$-11.0M$-20.0M$-23.0M
Investing Cash Flow$-2.0M$0$0
Financing Cash Flow$0$0$-3.0M
Net Cash Flow$9.0M$-5.0M$1.0M
Free Cash Flow$-12.0M$-20.0M$-23.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.34
EV / EBITDA-10.13
FCF Yield-9.05%
Quick Ratio2.44
Interest Coverage0.00
Return 1Y55.29%
Return 3Y—
Return 5Y—

Ownership

Insiders Held32.09%
Institutions Held8.14%
Institutions Float Held11.99%
Institutional HolderSharesReport Date
Blackrock Inc.1,304,4212026-03-31
Vanguard Capital Management LLC1,026,2692026-03-31
Geode Capital Management, LLC435,1542026-03-31
State Street Corporation256,0412026-03-31
Vanguard Portfolio Management LLC164,3862026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $334.73 -1.67% 38.93 $4.92T 0.32%
MSFTMicrosoft Corporation $535.03 +2.38% 28.68 $3.97T 0.76%
GOOGLAlphabet Inc. $354.31 +1.73% 16.94 $4.29T 0.26%
AMZNAmazon.com, Inc. $261.46 +2.91% 19.82 $2.81T 0.00%
METAMeta Platforms, Inc. $724.11 +0.45% 27.93 $1.84T 0.28%

About CapsoVision, Inc.

CapsoVision, Inc. is led by CEO Kang-Huai Wang, employs 90 people, headquartered in US, publicly traded since 2001.

CapsoVision, Inc. (CV) stock trades at $6.64 with a market capitalization of $331.76M. The stock is valued at a price-to-earnings (P/E) ratio of -9.79, price-to-book of 23.40, price-to-sales of 22.19. Over the past 52 weeks the stock has ranged between $4.38 and $15.37, and currently trades 56.8% below its 52-week high.

On profitability, CapsoVision, Inc. generates a return on equity (ROE) of -177.85%, return on capital employed of -164.32%, an operating margin of -185.71%, a net profit margin of -214.74%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1178.88 +0.79% JNJ Johnson & Johnson $260.66 +1.63% ABBV AbbVie Inc. $277.31 +1.80% MRK Merck & Company, Inc. Common Stock (new) $145.34 +2.08% UNH UnitedHealth Group Incorporated Common Stock (DE) $376.24 +1.43% NVS Novartis AG $143.26 +0.10% AZN AstraZeneca PLC $159.80 +0.64% TMO Thermo Fisher Scientific Inc $658.31 +0.97% AMGN Amgen Inc. $413.31 +1.44% GILD Gilead Sciences, Inc. $151.18 +2.77% ABT Abbott Laboratories $99.69 +1.21% NVO Novo Nordisk A/S $38.39 +0.54%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides